These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38278654)

  • 1. Real or imagined: We need a new scale for psychosis in Parkinson's disease.
    Pontone GM; Mills KA; Dobkin RD; Hinkle JT; Nirenberg MJ; Schneider RB;
    Parkinsonism Relat Disord; 2024 Apr; 121():106004. PubMed ID: 38278654
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
    Kulick CV; Montgomery KM; Nirenberg MJ
    Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hallucinations and the spectrum of psychosis in Parkinson's disease.
    Frei K; Truong DD
    J Neurol Sci; 2017 Mar; 374():56-62. PubMed ID: 28108020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease psychosis: presentation, diagnosis and management.
    Schneider RB; Iourinets J; Richard IH
    Neurodegener Dis Manag; 2017 Dec; 7(6):365-376. PubMed ID: 29160144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the scale for assessment of positive symptoms in Parkinson's disease psychosis.
    Voss TS; Brocht AF; Ravina B
    Mov Disord; 2010 Jan; 25(1):124-5. PubMed ID: 19412941
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and Characteristics of Psychosis in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Chendo I; Silva C; Duarte GS; Prada L; Voon V; Ferreira JJ
    J Parkinsons Dis; 2022; 12(1):85-94. PubMed ID: 34806620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.
    Fénelon G
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):18-25. PubMed ID: 18323763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of neurotransmitters in the development of Parkinson's disease-related psychosis.
    Factor SA; McDonald WM; Goldstein FC
    Eur J Neurol; 2017 Oct; 24(10):1244-1254. PubMed ID: 28758318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of psychotic symptoms in a community-based Parkinson disease sample.
    Mack J; Rabins P; Anderson K; Goldstein S; Grill S; Hirsch ES; Lehmann S; Little JT; Margolis RL; Palanci J; Pontone G; Weiss H; Williams JR; Marsh L
    Am J Geriatr Psychiatry; 2012 Feb; 20(2):123-32. PubMed ID: 21617521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of Cannabis on hallucinations in Parkinson's disease patients.
    Cravanas B; Frei K
    J Neurol Sci; 2020 Dec; 419():117206. PubMed ID: 33161300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychosis in Parkinson's disease].
    Rongve A; Auning E; Ehrt U; Arsland D
    Tidsskr Nor Laegeforen; 2012 Jan; 132(2):155-8. PubMed ID: 22278271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scales to evaluate psychosis in Parkinson's disease.
    Goetz CG
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S38-41. PubMed ID: 20083004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive correlates of hallucinations and delusions in Parkinson's disease.
    Factor SA; Scullin MK; Sollinger AB; Land JO; Wood-Siverio C; Zanders L; Freeman A; Bliwise DL; McDonald WM; Goldstein FC
    J Neurol Sci; 2014 Dec; 347(1-2):316-21. PubMed ID: 25466695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis.
    Panchal SC; Ondo WG
    Curr Psychiatry Rep; 2018 Jan; 20(1):3. PubMed ID: 29374325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.
    Fénelon G; Soulas T; Zenasni F; Cleret de Langavant L
    Mov Disord; 2010 Apr; 25(6):763-6. PubMed ID: 20437542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosis.
    Sabbagh M; Small GW; Isaacson SH; Torres-Yaghi Y; Pagan F; Pahwa R
    Int J Psychiatry Clin Pract; 2023 Mar; 27(1):69-81. PubMed ID: 35574992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hallucinations and psychosis in Parkinson's disease.
    Rabey JM
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S105-10. PubMed ID: 20123547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.
    Williams-Gray CH; Foltynie T; Lewis SJ; Barker RA
    CNS Drugs; 2006; 20(6):477-505. PubMed ID: 16734499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease psychosis 2010: a review article.
    Friedman JH
    Parkinsonism Relat Disord; 2010 Nov; 16(9):553-60. PubMed ID: 20538500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.